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Abstract: Metabolic Syndrome is a cluster of risk factors which often includes central obesity,
dyslipidemia, insulin resistance, glucose intolerance, hypertension, endothelial dysfunction, as well
as a pro-inflammatory, pro-oxidant, and pro-thrombotic environment. This leads to a dramatically
increased risk of developing type II diabetes mellitus and cardiovascular disease, which is the leading
cause of death both in the United States and worldwide. Increasing evidence suggests that berry fruit
consumption has a significant potential in the prevention and treatment of most risk factors associated
with Metabolic Syndrome and its cardiovascular complications in the human population. This is
likely due to the presence of polyphenols with known antioxidant and anti-inflammatory effects,
such as anthocyanins and/or phenolic acids. The present review summarizes the findings of recent
dietary interventions with berry fruits on human subjects with or at risk of Metabolic Syndrome.
It also discusses the potential role of berries as part of a dietary strategy which could greatly reduce
the need for pharmacotherapy, associated with potentially deleterious side effects and constituting a
considerable financial burden.
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1. Metabolic Syndrome: General Overview
Metabolic Syndrome is characterized by the simultaneous presence of multiple risk factors, which
are a direct or indirect consequence of both insulin resistance and overweight/obesity [1]. Although
it is not a disease in itself, this combination of health problems dramatically increases the risk of
developing type II diabetes mellitus and cardiovascular disease [2].
The US National Cholesterol Education Program–Adult Treatment Panel III (ATPIII) defines
Metabolic Syndrome as the combined occurrence of at least three of the following five risk factors:
abdominal obesity (waist circumference≥102 cm in males,≥88 cm in females); high blood triglycerides
(≥150 mg/dL); low HDL cholesterol (≤40 mg/dL in males, ≤50 mg/dL in females); high diastolic
and/or systolic blood pressure (≥130/85 mmHg) and high fasting blood glucose (≥100 mg/L) [2].
Together with these diagnostic parameters, which were selected because of their widespread
use in the clinical setting, a plethora of other dysfunctional states are often associated with Metabolic
Syndrome. Although they are not used for diagnostic purposes, they significantly contribute to the
increased cardiovascular risk and the onset of type II diabetes mellitus [2]. In particular, Metabolic
Syndrome is associated with a pro-oxidant, pro-inflammatory, and pro-thrombotic state [3,4].
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Chronic, low-grade, systemic inflammation is one of the landmark characteristics of Metabolic
Syndrome, leading to unnecessary tissue damage, endothelial dysfunction, thrombosis, insulin
resistance, high blood pressure, and all the pathologies related to such risk factors, including
cardiovascular disease, diabetes, some forms of cancer, arthritis, neurodegenerative diseases, and
many others [3,4].
Fat accumulation and obesity are major underlying causes of chronic inflammation, due to the
inherent ability of adipocytes to secrete inflammatory mediators: mainly adipocyte-derived cytokines
(called adipokines), but also hormones like leptin [5].
Inflammation and fat accumulation both lead to impairment in glucose metabolism and insulin
resistance, and in turn, impaired glucose metabolism exacerbates inflammation and tissue damage,
thus sustaining a pro-inflammatory state and endothelial dysfunction [6,7].
Indeed, another landmark characteristic of Metabolic Syndrome is the development of endothelial
dysfunction, which is strictly related to oxidative stress and inflammation via the nuclear factor
kappa-b pathway [1].
Endothelial dysfunction is characterized by an imbalance between vasoconstrictor and vasodilator
responses leading to impaired vascular tone, peripheral vascular resistance, and organ perfusion,
and is one of the earliest events in the development of atherosclerotic lesions. Metabolic Syndrome
is often associated with impaired endothelium-dependent vasodilation, likely due to insufficient
NO production or bioavailability, [8] and with exaggerated vasoconstriction, due to an increased
production of vasoconstricting mediators [9].
2. The Role of Berries in the Modulation of Metabolic Syndrome
Berries represent a variety of small fruits characterized by the red, purple, and blue color. The most
common berries are: blueberry, bilberry, cranberry, blackberry, raspberry, black, white or red currant,
and strawberry. Minor berries include: lingonberry, cloudberry, elderberry, honeyberry, whortleberry,
and chokeberry.
Berries are consumed both as fresh product as well as processed foods (i.e., juices, beverages,
jams, freeze-dried). They contain high levels of polyphenols including flavonoids (anthocyanins,
flavonols, and flavanols), condensed tannins (proanthocyanidins), hydrolyzable tannins (ellagitannins
and gallotannins), phenolic acids (hydroxybenzoic and hydroxycinnamic acids, chlorogenic acid),
stilbenoids and lignans [10,11]. Their concentration varies according to species, genotype, growing
and post-harvesting conditions [12].
Anthocyanins (ACNs) are probably the main bioactive compounds that characterize berries
with pelargonidin, cyanidin, delphinidin, petunidin, peonidin, and malvidin the most predominant
ACN compounds. They are found mainly in the external layer of the pericarp. ACNs include
aglycones–anthocyanidins and their glycosides–anthocyanins. They differ with regard to the position
and number of hydroxyl groups, degree of methylation, type and number of sugar molecules (mono-,
di- or tri-glycosides), type of sugars (the most common sugars include glucose, galactose and arabinose)
and type and number of aliphatic or aromatic acids (i.e., p-coumaric, caffeic, ferulic acid). Among
berries, blackcurrants, black elderberries, blackberries and blueberries are particularly rich in ACNs
(400 to 500 mg/100 g) [13]. Phenolic acids are represented by hydroxycinnamic acids (i.e., ferulic, caffeic,
p-cumaric acids. and caffeoylquinic esters) and benzoic acid derivatives (i.e., gallic acid, salicylic,
p-hydroxybenzoic. and ellagic acids). They occur mainly in bound forms as esters or glycosides. Gallic
acid and chlorogenic acids are abundant in blueberry (~200 mg/100 g) and blackberry (~300 mg/100 g).
Ellagic acid is the main phenolic acid in strawberries (from 300 mg to 600 mg/100 g) where it is present
in free form or esterified to glucose in hydrolysable ellagitannins. Blueberries and cranberries are also
important sources of ferulic acid, bilberries and blackcurrants of p-coumaric and caffeic acid, while
chokeberries are rich sources of caffeic, chlorogenic, and neochlorogenic acids [13].
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Flavonols, 3-hydroxyflavones and tannins are also widespread in berries. Flavan-3-ols are a
complex subclass of polyphenols without glycoside residues and with different levels of polymerization
ranging from monomeric, oligomeric, and polymeric forms. Tannins include both condensed
non-hydrolysable tannins known as proanthocyanidins, and esters of gallic and ellagic acids called
hydrolysable tannins. Tannins play an essential role in defining the sensory properties of fresh fruit and
fruit-derived products. They are responsible for the taste and changes in the color of fruit and fruit juice.
Moreover, tannins stabilize ACNs by binding to form co-polymers. The amount of flavan-3-ols and
proanthocyanidins in chokeberries, blueberries, and strawberries varies from 150 mg to 700 mg/100 g,
while in blackberries and raspberries the amount is about 300 mg/100 g [13].
Blackberries, blueberries, and strawberries are rich sources of ellagitannins (up to 600 mg/100 g),
followed by chokeberries, cloudberries and red raspberries (~260 mg/100 g), while small quantities of
tannins are found in honeyberries [13].
During recent years, a multitude of clinical research studies have focused on the health properties
of berries. In particular, increasing attention has been devoted to the role of berries and their
components in the modulation of oxidative stress [14], vascular function [15], inflammation, and
lipid metabolism [16]. In addition, research studies have explored the role of berries on chronic
diseases such as cardiovascular diseases, diabetes, and obesity with promising, albeit preliminary,
results. Several studies have also investigated the effect of berry consumption on their ability to
modulate/attenuate risk factors associated with Metabolic Syndrome.
A search of the literature on intervention studies investigating the effect of berry consumption
in the modulation of Metabolic Syndrome and/or related risk factors was carried out. Abstracts and
full texts from human acute and chronic intervention studies were screened. PUBMED, ScienceDirect,
and ScholarGoogle databases were searched to identify articles published later than 1 January 2000.
The searches used the following terms and text words alone and in combination: “berry”, “Metabolic
Syndrome”, “overweight”, “obesity”, “hypertension”, “hypercholesterolemia”, “hyperlipemia”,
“Type II diabetes”, and ”humans”. Interventions conducted in healthy subjects (not presenting
any of the risk factors characterizing Metabolic Syndrome) were excluded. Reference lists of the
obtained articles were also searched for related articles. The search was limited to English-language
articles. A total of 45 articles were obtained from the database searches and from their reference lists.
Four papers were excluded because studies were performed with a mix of fruits and vegetables and
other foods in which berries did not constitute the main food [17–20]. Therefore after exclusions,
a total of 41 studies were included in the review (Figure 1). Thirty-four explored a medium-long
term intervention, four were post-prandial while three investigated both or performed a chronic
intervention followed by an acute study. Here, we summarize the main results of the human studies.
The results obtained are also reported in Table 1, describing the type of food or supplement, number
of intervention days, number of subjects and their characteristics, dose/day of test food, the use of
control/placebo food, and the significant findings.
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Table 1. Effect of berry consumption on Metabolic Syndrome and associated risk factors.
Berry Intervention Participants Dose Main findings References
Blueberry
8-week, randomized,
double-blind,
placebo-controlled,
parallel intervention
Forty-eight postmenopausal women
(Blueberry group: BMI 30.1 ± 5.94 kg/m2;
age 59.7 ± 4.58 year; Control group:
BMI 32.7 ± 6.79 kg/m2; age 57.3 ± 4.76 year)
with pre- and stage 1-hypertension
Blueberry group: 480 mL blueberry drink
(22 g freeze-dried blueberry powder
corresponding to 1 fresh cup blueberries)
Control group: 480 mL placebo drink
↓systolic, diastolic blood pressure and
brachial-ankle pulse wave velocity
↑NO plasma levels
↑superoxide dismutase activity after
blueberry and control group
=weight, waist circumference, CRP
Johnson et al.
[21]
6-week randomized,
double-blind,
placebo-controlled,
parallel intervention
Forty-four subjects with metabolic syndrome
(Blueberry group: BMI 35.2 ± 0.8 kg/m2;
age 55 ± 2 year; Control group:
BMI 36.0 ± 1.1 kg/m2; age 59 ± 2 year)
Blueberry group: Smoothie prepared with
45 g blueberry powder
Control group: identical smoothie without
blueberry bioactives
↑endothelial function
=blood pressure and insulin sensitivity Stull et al. [22]
6-week, randomized,
placebo-controlled,
crossover intervention
Eighteen male (BMI 24.8 ± 2.6 kg/m2;
age 47.8 ± 9.7 year) with CVD risk factors
Wild blueberry group: 250 mL blueberry
drink (25 g WB powder, equivalent to 148 g
fresh WB)
Control group: 250 mL water with sensory
characteristics similar to the WB drink
↓Endogenous and oxidatively-induced DNA
damage in PBMCs
=lipid profile, weight, markers of
inflammation and endothelial function,
dietary markers, DNA repair activity
Riso et al. [23]
6-week, randomized,
double-blinded,
placebo-controlled,
parallel intervention
Twenty-seven (BMI between 32 and 45 kg/m2;
age > 20 year) obese, insulin-resistant subjects
Blueberry group: smoothie prepared with
45 g of blueberry powder (22.5 g twice a day)
(equivalent to 2 cups of fresh blueberries)
Control group: identical smoothie without
blueberry bioactives
↑insulin sensitivity
=markers of inflammation, lipid profile and
blood pressure
Stull et al. [24]
8-week, randomized,
single-blinded, controlled
parallel intervention
Forty-eight subjects with metabolic syndrome
(4 males and 44 females; BMI 37.8 ± 2.3 kg/m2;
age 50.0 ± 3.0 year)
Blueberry group: 480 mL blueberry drink
(50 g freeze-dried blueberries corresponding
to 350 g fresh berries)
Control group: 480 mL water
↓systolic and diastolic blood pressure
↓plasma ox-LDL, MDA and HNE levels
=lipid profile, weight, waist circumference,
inflammation markers
Basu et al. [25]
Bilberry
8-week, randomized,
controlled, parallel
intervention
Twenty-seven subjects (Bilberry group:
BMI 31.4 ± 4.7 kg/m2; age 53 ± 6 year; Control
group: 32.9 ± 3.4 year; age 50 ± 7 year) with
metabolic syndrome
Bilberry group: 200 g of bilberry purée and
40 g of dried bilberries (eq. 200 g of fresh
bilberries)
Control group: habitual diet. The use of
berries was allowed at maximum of
1 dL/day (corresponding to 80 g/day).
↓serum levels of hs-CRP, IL-6, IL-12 and
inflammation score.
↓expression of MMD and CCR2 transcripts
associated with monocyte and macrophage
function associated genes
=body weight, glucose, and lipid profile
Kolehmainen
et al. [26]
5-week, randomized,
cross-over intervention
Eighty overweight and obese women
(BMI 29.6 ± 2.1 kg/m2; age 44.2 ± 6.2 year;
21 subjects meeting metabolic syndrome criteria)
Bilberry group: 100 g fresh bilberries
Sea buckthorn group: Sea buckthorn (SB),
SB fractions or SB oils (equivalent to
100 g of berries)
Control group: none
↓body weight, waist circumference,
VCAM-1, TNF-α, adiponectin
↑insulin, GHbA1C
=fat percent, blood pressure, fasting plasma
cholesterol, triacylglycerol, ALAT and IL-6
serum levels
Lehtonen et al.
[27]
4-week, randomized,
controlled, parallel
intervention
Sixty-two subjects (Bilberry group: BMI range
19.9–31.7 kg/m2; age range 34–68 year; Control
group: BMI range 17.8–31.5 kg/m2; age range
30–68 year) with CVD risk factors
Bilberry group: 330 mL bilberry juice/day
(diluted to 1 L using tap water)
Control group: 1 L of water
↓serum levels of CRP, IL-6, IL-15,
TNF-α, MIG
=markers of antioxidants status and
oxidative stress
Karlsen et al.
[28]
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Table 1. Cont.
Berry Intervention Participants Dose Main findings References
Cranberry
4-week,
placebo-controlled
double-blind, crossover
intervention
Thirty-five abdominally obese men
(age 45 ± 10 year, BMI 28.3 ± 2.4 kg/m2 and a
waist circumference ≥90 cm) with metabolic
(n = 13) and without metabolic syndrome (n = 22)
Cranberry group: 500 mL/day of either
low-calorie juice (27% juice)
Control group: 500 mL/day placebo juice
↓arterial stiffness and global endothelial
function
=blood pressure, markers of endothelial
function
Ruel et al. [29]
60 days, parallel
intervention
Fifty-six subjects (cranberry group: BMI
30.9 kg/m2 median, age 51.0 year median; control
group: BMI 34.0 kg/m2 median, age 48.5 year
median) with metabolic syndrome
Cranberry group: 700 mL/day
reduced-energy cranberry juice
Control group: usual diet
↓serum homocysteine levels,
lipoperoxidation, protein oxidation
↑serum folic acid levels
=metabolic and inflammatory biomarkers
C-reactive protein, TNF-α, IL-1 and IL-6
Simão et al. [30]
12-week, randomized,
double-blind, parallel
intervention
Fifty-eight (BMI 28.8 ± 3.6 kg/m2,
age 54.8 ± 9.1 year) Type II diabetic subjects
Cranberry group: 240 mL/day cranberry
juice
Control group: 240 mL/day placebo juice
↓glucose, ApoB
↑ApoA-1, PON-1 activity
=lipoprotein(a)
Shidfar et al. [31]
Post-prandial 4-week,
randomized,
placebo-controlled,
cross-over intervention
Fifteen (BMI not reported, age 62 ± 8 year, 13%
female) subjects with coronary artery diseases
Forty-seven subjects with coronary artery diseases
(cranberry group: BMI 30 ± 5 kg/m2,
age 61 ± 11 year; Control group: BMI
29 ± 4 kg/m2, age 63 ± 9 year)
Cranberry group: 480 mL cranberry juice
Control group: None
Cranberry group: 480 mL/day cranberry
juice
Control group: 480 mL/day placebo juice
↑flow mediated dilation and lnPAT score as
markers of endothelial function
=blood pressure, heart rate, brachial
diameter, hyperemic flow
↓carotid-femoral pulse wave velocity
(a measure of central aortic stiffness). and
HDL-cholesterol after cranberry juice
=lipid profile, glucose, insulin, HOMA-IR,
C-reactive protein, ICAM-1 serum levels,
brachial artery flow-mediated dilation,
digital pulse amplitude tonometry, blood
pressure, and carotid-radial pulse wave
velocity
Dohadwala et al.
[32]
8-week, randomized
double-blind,
placebo-controlled,
parallel intervention
Thirty-one (BMI 40.0 ± 7.7 kg/m2,
age 52.0 ± 8.0 year) female with metabolic
syndrome
Cranberry group: 480 mL/day cranberry
juice
Control group: 480 mL/day placebo drink
↓ox-LDL, MDA & HNE plasma/serum
levels
↑Total plasma antioxidant capacity
=blood pressure, glucose, plasma
lipoprotein-lipid, markers of inflammation
Basu et al. [33]
Post-prandial cross-over
intervention
Thirteen (6 female and 7 male)
noninsulin-dependent subjects
(age 61.6 ± 2.3 year, BMI 33.25 ± 1.22 kg/m2)
Cranberry group:
Group 1: raw cranberry (55 g, 21 cal, 1 g fiber)
Group 2: sweetened dried cranberry (40 g,
138 cal; 2.1 g fiber)
Group 3: sweetened dried cranberries-less
sugars group (40 g; 113 cal; 1.8 g fiber + 10 g
polydextrose)
Control group: white bread (57 g, 160 cal;
1 g fiber)
↓glycemic and insulinemic response
following SDC-LS Wilson et al. [34]
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Table 1. Cont.
Berry Intervention Participants Dose Main findings References
12-week intervention
(three 4-week intervention
with 125, 250 and
500 mL/day
cranberry juice)
Thirty (BMI 27.8 ± 3.2 kg/m2, age 51 ± 10 year;
9 subjects with metabolic syndrome and 21 without
metabolic syndrome) abdominally obese men
Cranberry group: 125, 250 and 500 mL/day
cranberry juice
Control group: none
↓ox-LDL following 250 and 500 mL
cranberry juice
↓systolic blood pressure, s-VCAM, ICAM
plasma levels following 500 mL cranberry
juice
↓ox-LDL, ICAM plasma levels in subjects
with metabolic syndrome following 12-week
intervention
↑HDL cholesterol following 250 and 500 mL
cranberry juice
=Total, LDL Apo B cholesterol, triglycerides,
diastolic blood pressure, heart beat,
E-selectin plasma levels
Ruel et al. [35]
12-week, randomized,
placebo-controlled,
double-blind, parallel
intervention
Thirty (16 males and 14 females) Type II diabetic
subjects (Cranberry group: 9/6 male/female, BMI
26.2 ± 0.7 kg/m2, age 65 ± 2 year; Control group:
7/8 male/female, BMI 25.9 ± 1.0 kg/m2,
age 66 ± 2 year)
Cranberry group: 500 mg/capsule cranberry
powder extract, three times a day
Control group: 500 mg/capsule placebo
↓Total cholesterol, Total: HDL cholesterol
ratio, LDL cholesterol
=waist circumference, BMI, fasting serum
glucose, insulin, HbA1c, HOMA insulin
resistance, C-reactive protein, blood
pressure, ox-LDL, triglyceride,
HDL-cholesterol levels, uric acid
Lee et al. [36]
Post-prandial intervention Twelve (6 male and 6 female) type II diabeticsubjects (age 65.3 ± 2.3 year, BMI 34.7 ± 1.6 kg/m2
Cranberry group:
Group 1: normal calorie cranberry juice
(NCCBJ; 27% cranberry juice, v/v;
130 Cal/240 mL)
Group 2: unsweetened low-calorie cranberry
juice (LCCBJ; 27%, v/v CBJ; 19 Cal/240 mL)
Control group: Group 1: normal calorie
control (NCC; 140 Cal/240 mL) made with
dextrose
Group 2: low-calorie control (LCC;
19 Cal/240 mL)
↓plasma insulin and glycemic response
following LCCBJ Wilson et al. [37]
12-week intervention
(three 4-week intervention
with 125, 250, and
500 mL/day
cranberry juice)
Thirty (BMI 27.8 ± 3.3 kg/m2, age 51 ± 10 year)
abdominally obese men
Cranberry group: 125, 250 and 500 mL/day
cranberry juice
Control group: none
↓body weight, BMI, waist circumference,
waist-to-hip ratio, total:HDL cholesterol apo
B, after intervention with 250 and 500 mL
cranberry juice
↑plasma nitrite/nitrate following
intervention with 500 mL
↑plasma antioxidant capacity following
250 and 500 mL cranberry juice
↑HDL cholesterol following 250 mL
cranberry juice
=Total, LDL and VLDL cholesterol
Ruel et al. [38]
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Table 1. Cont.
Berry Intervention Participants Dose Main findings References
2-week intervention
Twenty-one (BMI 26.9 ± 3.8 kg/m2,
age 38 ± 8 year) abdominally
obese-dyslipidemic men
Cranberry group: 7 mL/kg BW (range
460–760 mL/day cranberry juice)
Control group: none
↓BMI, plasma ox-LDL levels
↑Total plasma antioxidant capacity
=waist and hip circumference, waist/hip
ratio, blood pressure, plasma
lipoprotein-lipid, inflammation markers
Ruel et al. [39]
12-week randomized,
controlled, parallel
intervention
Twenty-seven Type II diabetic subjects (cranberry
group: 14 subjects, 6 women and 8 men, BMI not
reported, age 57.9 ± 10.6 year; placebo group:
13 subjects 6 women and 7 men, BMI not reported,
age 52.6 ± 13.7 year)
Cranberry group: 6 capsules (equivalent to
240 mL cranberry juice) containing cranberry
juice concentrate powder
Control group: 6 capsules containing
placebo powder
↑insulin levels after placebo treatment
=fasting serum glucose, HbA1c,
fructosamine, triglyceride, HDL,
LDL-cholesterol levels
Chambers &
Camire [40]
Raspberry
14-day (4-day
black-raspberry intake,
post-prandial,
randomized, cross-over
intervention, wash-out
and 4-day black-raspberry
intake)
Ten older overweight and obese (BMI,
31.4 ± 2.7 kg/m2, age 64.7 ± 6.9 year) males
Berry group: 45 g/day of lyophilized black
raspberry powder for 4 days + high fat meal
post prandial
Control group: No black raspberry + high
fat meal post prandial
↓serum IL-6 levels
=TNF-α, CRP Sardo et al. [41]
12-week, randomized,
controlled, parallel
intervention
Seventy-seven subjects (berry group: BMI,
26.3 ± 4.3 kg/m2, age 58.0 ± 9.2 year; control
group: BMI, 25.1 ± 4.0 kg/m2, age 60.1 ± 9.5 year)
with metabolic syndrome
Berry group: 750 mg/day of black raspberry
powder as capsules
Control group: 750 mg/day of cellulose,
isomalto, and corn powder as capsules
↓total cholesterol level total
cholesterol/HDL ratio IL-6, TNF-α
↑flow mediated dilation, adiponectin
=serum lipid profile, CRP, ICAM and VCAM
Jeong et al. [42]
Chokeberry 4-week intervention Twenty-three subjects (BMI, not reported,age 47.5 ± 10.4 year) with hypertension
Berry group: 200 mL/day of
polyphenol-rich organic chokeberry juice
Control group: none
↓systolic and diastolic blood pressure, heart
rate high-frequency power, heart rate very
low frequency, standard deviation of normal
RR intervals Holter ECG
=lipid profile, glucose, CRP, urea, creatinine,
Ac. uricum, AST, ALT, markers related to
short term heart rate and Holter ECG
Kardum et al.
[43]
4-week intervention Twenty women (BMI, 36.1 ± 4.4 kg/m
2;
age 53.0 ± 5.4 year) with abdominal obesity
Berry group: 100 mL/day
glucomannan-enriched (2 g), chokeberry
juice-based
Control group: none
↓BMI, waist circumference, systolic blood
pressure, serum HDL cholesterol,
erythrocytes monounsaturated fatty acids,
n6/n3 ratio
↑erythrocytes n3 polyunsaturated fatty acids
=erythrocytes saturated and n6
polyunsaturated fatty acids, unsaturation
index, diastolic blood pressure, lipid profile,
glucose and enzymatic activity
(SOD, CAT, GPx)
Kardum et al.
[44]
8-week intervention
Fifty-two subjects (42–65 years old; berry group:
38 subjects, BMI 31.1 ± 3.3 kg/m2; control group:
14 healthy subjects; BMI 24.4 ± 1.5 kg/m2) with
metabolic syndrome
Berry group: 300 mg/day chokeberry extract
Control group: No intervention
↓serum total and LDL cholesterol,
triglycerides, coagulation and platelet
aggregation parameters
=BMI, waist circumference, serum
HDL cholesterol
Sikora et al. [45]
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Table 1. Cont.
Berry Intervention Participants Dose Main findings References
18-week (6-week
intervention + 6-week
wash-out + 6 week
intervention) intervention
Fifty-eight men (BMI 27.7 ± 2.9 kg/m2;
age 54.1 ± 5.6 year) with mild
hypercholesterolemia
Berry group: 150 mL/day chokeberry juice
Control group: none
↓serum total and LDL cholesterol,
triglycerides, glucose, homocysteine and
fibrinogen, blood pressure
↑serum HDL2 cholesterol
=serum HDL and HDL3 cholesterol, hs-CRP,
lipid peroxides, uric acid
Skoczyñska et al.
[46]
Strawberry
Post-prandial,
randomized, controlled,
4-arm, crossover
intervention
Twenty-one (BMI 40.2 ± 7.2 kg/m2;
age 39.8 ± 13.8 year) subjects with abdominal
obesity and insulin-resistance
Berry group:
Group 1: 10 g freeze-dried whole strawberry
powder FDS
Group 2: 20 g FDS
Group 3: 40 g FDS
Control group: 0 g FDS
↓plasma insulin, insulin: incremental
increase, glucose: incremental increase,
insulin: glucose ratio after 40 g FDS
consumption
=plasma glucose, TG, ox-LDL, IL-6
Park et al. [47]
12-week, randomized,
controlled, parallel
intervention
Sixty volunteers with CVD risk factors
LD-FDS: 15 subjects (14 females/1 male;
BMI, 34.5 ± 4.4 kg/m2; age, 50 ± 10 year)
HD-FDS: 15 subjects (13 females/2 males;
BMI, 38.0 ± 7.1 kg/m2; age, 49 ± 11 year)
LD-C: 15 subjects (14 females/1 male;
BMI, 37.0 ± 4.4 kg/m2; age, 48 ± 10 year)
HD-C: 15 subjects (14 females/2 male;
BMI, 35.0 ± 5.2 kg/m2; age 48 ± 10 year)
Berry group:
Group 1: low dose freeze-dried strawberries
(LD-FDS): 25 g of freeze-dried powder
reconstituted in 2 cups (474 mL/day) of
water daily (corresponding to 250 g of fresh
strawberries);
Group 2: high dose freeze-dried strawberries
(HD-FDS): 50 g of freeze-dried powder
reconstitute in 2 cups (474 mL/day) of water
(corresponding to 500 g of fresh strawberries)
Control group:
Group 1: Low-dose calorie- and
fiber-matched control (LD-C)
Group 2: high-dose calorie- and
fiber-matched control (HD-C)
↓serum total and LDL-cholesterol, derived
small LDL particles, MDA and HNE levels
following HD-FDS intervention.
↓MDA and HNE following LD-FDS
intervention
=serum glucose, HbA1c, insulin, HDL,
VLDL-cholesterol, HOMA-IR, TG, VACM-1,
ICAM-1, hs-CRP
Basu et al. [48]
6-week, randomized,
double-blind, controlled,
parallel intervention
Thirty-six diabetic subjects (berry group: n = 19;
BMI, 27.36 ± 4.23 kg/m2; age 51.9 ± 8.2 year;
control group: n = 17; BMI, 28.58 ± 4.7 kg/m2;
age 51.1 ± 13.8 year)
Berry group: 2 cups freeze-dried
strawberry (50 g/day)
Control group: 2 cups iso-caloric drink with
strawberry flavoring
↓diastolic blood pressure
=serum TG, total cholesterol, ratio total
cholesterol/HDL-cholesterol, systolic blood
pressure, anthropometric indices
Amani et al. [49]
6-week, randomized
double-blind controlled
intervention
Thirty-six subjects (23 females/13 males) with type
2 diabetes (berry group: 19 diabetic subjects; BMI,
27.32 ± 3.26 kg/m2; age, 51.88 ± 8.26 year; control
group: 17 diabetic subjects; BMI,
28.70 ± 4.24 kg/m2, age, 51.17 ± 13.88 year)
Berry group: 50 g/day freeze-dried
strawberry (equivalent to 500 g fresh
strawberries)
Control group: Placebo powder
↓MDA, HbA1c and hs-CRP serum levels
↑total serum antioxidant status
=serum glucose levels
Moazen et al.
[50]
7-week double-blind,
randomized, cross-over
intervention
Twenty obese subjects (BMI between 30 and
40 kg/m2, age between 20 and 50 year)
Berry group: Strawberry powder (amount
no reported) equivalent to 320 g/day of
frozen strawberries. Two servings of
strawberry powder mixed as a milkshake, in
yogurt, cream cheese, or water-based,
sweetened beverage
Control group: Milkshake, yogurt, cream
cheese, or water-based, sweetened beverage
↓Serum total cholesterol, small HDL
particles, LDL size, fibrinogen
=serum lipid profile, lipid particle
concentrations and size, inflammatory
markers and oxidative stress
Zunino et al. [51]
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Table 1. Cont.
Berry Intervention Participants Dose Main findings References
Post-prandial,
randomized, single-blind,
placebo-controlled,
cross-over intervention
Twenty-six overweight subjects (BMI,
29.2 ± 2.3 kg/m2; age, 50.9 ± 15.0 year)
Berry group: High-carbohydrate,
moderate-fat meal + strawberry drink
(10 g strawberry powder)
Control group: High-carbohydrate,
moderate-fat meal + placebo drink
↓serum hs-CRP, IL-6 and insulin levels
=serum levels of PAI-1, IL-1β, TNF-α,
glucose
Ederisinghe et al.
[52]
6-week, randomized,
single-blind,
placebo-controlled,
parallel intervention +
post-prandial high
carbohydrates fat meal
Twenty-four overweight and obese subjects
(BMI, 29.2 ± 2.3 kg/m2; age, 50.9 ± 15.0 year)
Berry group: 10 g/day strawberry powder
in 305 mL water
Control group: 10 g/day placebo powder in
305 mL water
=serum levels of glucose, insulin, hs-CRP,
IL-6, PAI-1, IL-1β, TNF-α after 6-week
intervention
↓serum PAI-1, IL-1β levels following 6-week
+ post-prandial intervention
=serum levels of glucose, insulin, hs-CRP,
IL-6, TNF-α after 6-week + post-prandial
intervention
Ellis et al. [53]
6-week, randomized,
single-blind,
placebo-controlled,
crossover intervention
After 6 weeks subjects
consumed a high fat meal
(post-prandial)
Twenty-four hyperlipidemic subjects (14 female,
10 male; BMI, 29.2 ± 2.3 kg/m2,
age 50.9 ± 15 year)
Berry group: Drinks containing 10 g/serving
of freeze-dried strawberry (equivalent to
110 g/day of fresh strawberries)
Control group: Placebo drink
↓serum total, LDL and HDL cholesterol, TG
after 6 weeks
=ox-LDL plasma levels after 6 weeks
↓LDL and HDL cholesterol, TG and ox-LDL
plasma levels after post-prandial compared
to control group
=serum total cholesterol after post-prandial
Burton-Freeman
et al. [54]
8-week intervention Twenty-seven subjects (BMI: 37.5 ± 2.15 kg/m
2;
age: 47.0 ± 3.0 year) with metabolic syndrome
Berry group: Four cups of strawberry drink
per day (each cup containing 25 g of
freeze-dried strawberry powder)
Control group: Four cups of water
↓total and LDL-cholesterol, small LDL
particles, VCAM-1
=glucose, triglycerides, HDL-cholesterol,
lipoprotein particle size and concentrations,
blood pressure, and waist circumference,
ICAM-1.
Basu et al. [55]
4-week intervention Sixteen female (mean BMI, 38.6 ± 2.3 kg/m
2;
range age, 39–71 year) with metabolic syndrome
Berry group: Two cups of strawberry drink
per day (each cup containing 25 g of
freeze-dried strawberry powder)
Control group: None
↓serum total and LDL-cholesterol, MDA and
HNE levels
=serum HDL, TG, HDL, VLDL-cholesterol,
hs-CRP, adiponectin, glucose, ox-LDL
plasma levels, blood pressure, body weight,
waist circumference
Basu et al. [56]
4-week, randomized,
controlled, cross-over
intervention
Twenty-eight hyperlipidemic subjects (range BMI,
19.8–32.3 kg/m2; range age, 38–75 years)
Berry group: 454 g/day strawberries
Control group: 65 g/day oat bran bread
↓MDA plasma absolute concentration and
molar ration of LDL-cholesterol at 4 weeks
compared to placebo
↑protein thiols concentration for both the
treatments compared to each baseline
=plasma levels of conjugated dienes, lipid
profile, C-reactive protein, blood pressure,
body weight
Jenkins et al. [57]
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Table 1. Cont.
Berry Intervention Participants Dose Main findings References
Whortleberry
4-week, randomized,
double-blind,
placebo-controlled,
parallel intervention
Fifty hyperlipidemic subjects (berry group:
twenty-five, 15 females/10 males; BMI,
25.40 ± 1.75 kg/m2; age, 48.08 ± 16.39 year;
control group: twenty-five hyperlipidemic subjects,
15 females/10 males; BMI, 25.21 ± 2.01 kg/m2;
age, 46.36 ± 16.59 year)
Berry group: 2 capsules/day whortleberry
capsules
Control group: 2 capsules/day placebo
capsules
↓serum total, LDL-cholesterol, TG and
plasma MDA levels
=serum HDL-cholesterol levels, hs-CRP
and BMI
Soltani et al. [58]
Berry mix
12-week, randomized,
double-blinded,
placebo-controlled
intervention
One hundred and thirty-three hypertensive
subjects (BMI, 26 ± 3 kg/m2, age 62 ± 6 year)
1 Berry group: 500 mL/day (MANA Blue
juice: red grapes, cherries, chokeberries and
bilberries)
2 Berry group: 500 mL/day (Optijuice:
MANA + polyphenol-rich extract from
blackcurrant press-residue)
3 Control group: 500 mL/day placebo
↓blood pressure Tjelle et al. [59]
12-week, randomized,
controlled, parallel
intervention
Twenty subjects (berry group: BMI,
31.8 ± 4.4 kg/m2, age 53.0 ± 6.5 year; control
group: BMI, 32.9 ± 3.4 kg/m2, age 49.8 ± 7.1 year)
with symptoms of metabolic syndrome
Berry group: 300 g/day fresh berries
comprising of 100 g of strawberry purée,
100 g of frozen raspberries, and 100 g of
frozen cloudberries
Control group: Usual diet
↓serum leptin levels
↑microbiota in both the groups
=blood pressure, serum lipid profile,
8-isoprostanes, resistin, TRAP assay
Puupponen-Pimiä
et al. [60]
20-week, randomized,
controlled, parallel
intervention
Sixty-one female subjects 35–52 years (berry group:
BMI 29.3 ± 2.2 kg/m2, control group: BMI
29.5 ± 1.8 kg/m2) with metabolic syndrome
Berry group: 163 g/day mix of northern
berries (lingonberry, sea buckthorn berry,
bilberry and black currant)
Control group: Usual diet
↓plasma ALT levels
↑plasma adiponectin levels
=blood pressure, lipid profile, glucose,
inflammatory markers, antioxidant capacity
Lehtonen et al.
[61]
Legend: BMI: body mass index; NO: nitric oxide; hs-CRP: high sensitive C-reactive protein; ICAM: Intercellular Adhesion Molecule 1; VCAM: Vascular cell adhesion molecule 1;
ALT/ALAT: alanine aminotransferase; TRAP: total radical trapping antioxidant parameter; TG: triglycerides; LDL: low density lipoprotein; ox-LDL: oxidized low density lipoprotein;
HDL: high density lipoprotein; MDA: malondialdehyde; PBMC: peripheral blood mononuclear cell; HNE: 4-hydroxynonenal; IL-1β: interleukin-1β; IL-6: interleukin-6; TNF-α:tumor
necrosis factor-alpha; PAI-1: plasminogen activator inhibitor-1; HOMA-IR: Insulin resistance index; GST: glutathione S-transferase; SOD: superoxide dismutase; GPx: glutathione
peroxidase; GHbA1C: Glycated hemoglobin A1C; PAT: peripheral arterial function; PON1: paraxonase1; MIG: monokine induced by interferon; MMD: monocyte to macrophage
differentiation associated; CCR2: chemokine (C-C motif) receptor 2.
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3. Blueberry
Depending on the size of the shrubs, blueberries are classified as either lowbush (‘wild’) or
highbush: Vaccinium corymbosum, a highbush blueberry, is the most commonly cultivated species
around the world, while Vaccinum angustifolium, native to North America, is the most widespread
species of wild blueberry [62]. Anthocyanins are the distinctive and most abundant class of phenolic
compounds in blueberries, and wild blueberries contain higher amounts of anthocyanins compared to
highbush blueberries. Blueberries also contain significant amounts of phenolic acids, flavonols and
flavan-3-ols, as well as manganese [63].
In an 8-week, controlled, randomized intervention, 48 middle-aged, obese subjects with Metabolic
Syndrome were given a daily blueberry drink made with 50 g freeze-dried blueberries, resulting in
significantly lower systolic and diastolic blood pressure, plasma oxidized LDLs, and malondialdehyde
(MDA) and 4-hydroxynonenal (HNE) concentrations. No significant changes were observed for
cholesterol and triglyceride levels, inflammatory markers CRP, adiponectin and IL-6, or adhesion
molecules ICAM-1 and VCAM-1 [25].
In a 6-week, placebo-controlled, randomized intervention, 27 obese, insulin-resistant subjects
received a daily smoothie made with 45 g of blueberry powder, which resulted in improved insulin
sensitivity but did not affect markers of inflammation, blood pressure, and blood lipid profile [24]. In a
subsequent 6-week intervention with the same experimental design on 44 obese subjects with Metabolic
Syndrome, endothelial function measured as peripheral arterial tone, significantly improved with
blueberry consumption, while blood pressure and insulin sensitivity did not significantly change [22].
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In a 6-week, placebo-controlled, cross-over, randomized intervention on 18 subjects with risk
factors for cardiovascular disease receiving a daily blueberry drink made of 25 g wild blueberry
powder, endogenous and ex vivo oxidatively-induced DNA damage in blood mononuclear cells
was found to be significantly lower, but no changes were observed in blood lipid profile, markers of
inflammation, and endothelial function [23].
In an 8-week, placebo-controlled, cross-over, randomized intervention on 48 overweight or obese
hypertensive women, administration of a daily drink made with 22 g of blueberry powder resulted
in significantly lower systolic and diastolic blood pressure and brachial-ankle pulse wave velocity,
and higher plasma levels of nitric oxide, but no changes in the inflammatory marker CRP [21].
In conclusion, the effect of blueberries in the modulation of Metabolic Syndrome-related risk
factors has been investigated in five interventions, documenting an effect on blood pressure, oxidative
stress, endothelial function, and insulin sensitivity, but not on inflammatory marker levels or blood
lipid profile.
4. Bilberry
Bilberries (Vaccinium myrtillus), the wild European blueberries, have a phenolic profile and content
which is comparable to that of blueberries, and are also exceptionally rich sources of anthocyanins.
In a 4-week, controlled, randomized intervention, 62 subjects with risk factors for cardiovascular
disease received 330 mL/day of bilberry juice, resulting in decreased serum concentrations of
inflammatory markers CRP, IL-6, IL-15 and TNF-α, while markers of antioxidant status and oxidative
stress remained unaffected [28].
When 100 g/day of fresh bilberries were given to 80 overweight or obese women with or without
Metabolic Syndrome for 5 weeks, body weight, waist circumference and concentrations of VCAM-1 and
TNF-α, but also adiponectin, significantly decreased, insulin and glycated hemoglobin concentrations
increased, while fat percent, blood pressure, blood lipids, and IL-6 levels were not affected [27].
In an 8-week, controlled, randomized intervention, in 27 overweight or obese subjects with
Metabolic Syndrome receiving 200 g/day of fresh bilberry purée and 40 g/day of dried bilberries,
serum concentrations of inflammatory markers hs-CRP, IL-6, IL-12, and LPS decreased, with no
changes in blood glucose and lipid profile [26].
Thus, the effect of bilberries on Metabolic Syndrome has not been fully investigated. To our
knowledge, only three interventions focused on this berry, finding a consistent effect on reducing
inflammation levels.
5. Cranberry
Native to North America, cranberry (Vaccinium macrocarpon) is a rich source of different phenolic
antioxidant compounds, primarily phenolic acids and flavonoids including anthocyanins, flavonols,
and flavan-3-ols [33]. Cranberries also contain resveratrols and the anti-inflammatory acetylsalicylic
acid [29].
A randomized, placebo-controlled intervention administering six daily capsules of cranberry
powder (equivalent to 240 mL cranberry juice) for 12 weeks to a group of 27 subjects with type 2
diabetes, did not detect any significant effect on blood glucose levels, glycated hemoglobin HbA1c,
triglyceride or cholesterol levels [40].
A 2-week intervention on 21 dyslipidemic men with abdominal obesity, reported improved total
plasma antioxidant capacity, and decreased BMI and plasma oxidized LDL levels following daily
consumption of 7 mL/kg BW of cranberry juice. Blood pressure, plasma lipid profile, and inflammatory
markers were not significantly affected [39].
When the effects of three different doses (125, 250, and 500 mL/day) of cranberry juice
administered sequentially for four weeks each, were tested on a group of 30 middle-aged
men with abdominal obesity, a significant reduction in body weight, BMI, waist circumference,
total/HDL-cholesterol ratio and apolipoprotein B, and a significant improvement in plasma total
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antioxidant capacity were reported after 250 mL and/or 500 mL consumption. A significant decrease
in plasma nitrite and nitrate, and increase in HDL cholesterol were reported only after the highest
dose. No significant effect was observed at the lowest dose, and no effect on total, LDL and VLDL
cholesterol was observed at any dose [38].
The same experimental design was tested on 30 middle-aged abdominally obese men, nine
of which with Metabolic Syndrome. HDL cholesterol and oxidized LDLs improved after 250 and
500 mL cranberry juice consumption, while systolic blood pressure and plasma ICAM-1 and VCAM-1
concentrations decreased only at the highest dose, with a stronger effect in the subset of subjects with
Metabolic Syndrome. No significant effect was observed at the lowest dose, and no effect on cholesterol,
triglycerides, diastolic blood pressure, and plasma E-selectin was observed at any dose [35].
When the post-prandial effect of a single-dose of sweetened cranberry juice was compared to
unsweetened cranberry juice in a group of 12 obese subjects with type 2 diabetes, only unsweetened
cranberry juice resulted in reduced plasma insulin levels and glycemic response, compared to both a
sweetened cranberry juice and an unsweetened control drink [37].
With a similar experimental design, the post-prandial effects of either raw cranberries, sweetened
dried cranberries or dried cranberries sweetened with less sugar were tested in 13 obese subjects with
type 2 diabetes. The effects of raw cranberries were the lowest on glycemic and insulinemic responses,
with the less sweetened, dried cranberries significantly lower compared to the fully sweetened
ones [34].
In a 12-week, placebo-controlled, randomized intervention, 30 older overweight subjects with
type 2 diabetes received a daily capsule of 500 mg cranberry powder extract, resulting in lower total and
LDL cholesterol, and total/HDL-cholesterol ratio. Blood glucose, insulin, and glycated hemoglobin
HbA1c levels were unaffected, as well as CRP, blood pressure, oxidized LDLs, triglycerides, and
HDL-cholesterol [36].
In a placebo-controlled, randomized intervention, 31 obese women with Metabolic Syndrome
were given 480 mL/day of cranberry juice for eight weeks, resulting in reduced circulating levels of
oxidized LDLs, malondialdehyde (MDA), and 4-hydroxynonenal (HNE), and improved total plasma
antioxidant capacity, while blood pressure, blood lipid and glucose levels, and inflammatory markers
did not change [33].
When a single-dose of 480 mL cranberry juice was administered to 15 subjects with coronary
artery disease, post-prandial endothelial function measured as brachial artery flow-mediated dilation,
it significantly improved (Dohadwala et al., 2011). When the same serving of cranberry juice was given
daily to a group of 44 subjects with coronary artery disease in a 4-week, placebo-controlled, cross-over
intervention, central aortic stiffness, measured as carotid-femoral pulse wave velocity, significantly
decreased, as well as HDL-cholesterol levels. However, no changes were reported for total and LDL
cholesterol, triglycerides, CRP, ICAM-1, blood pressure, carotid-radial pulse wave velocity or brachial
artery flow-mediated dilation [32].
In a 12-week, placebo-controlled, randomized intervention on 58 middle-aged, overweight or
obese subjects with type 2 diabetes, receiving 240 mL/day of cranberry juice, blood glucose, ApoB
and ApoA1 concentrations significantly decreased, PON-1 activity increased, while lipoprotein(a)
concentrations were unaffected [31].
When 56 overweight or obese subjects with Metabolic Syndrome were given 700 mL/day of
low-calorie cranberry juice for four weeks, serum folic acid levels significantly increased while serum
homocysteine levels, lipid and protein oxidation significantly decreased. Inflammatory markers CRP,
TNF-α, IL-1, and IL-6 did not change [30].
Thirty five abdominally obese men with or without Metabolic Syndrome were given 500 mL/day
of low-calorie 27% cranberry juice for four weeks in a placebo-controlled, cross-over intervention.
Measures of global endothelial function and arterial stiffness significantly decreased following
cranberry consumption compared to baseline, but not compared to post-placebo (Ruel et al., 2013 [29]).
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Blood pressure and serum markers of endothelial function ICAM-a, VCAM-1 and E-selectin, as well as
oxidized LDLs, did not change [29].
In summary, the effects of cranberries on markers of Metabolic Syndrome have been investigated
in eleven interventions, resulting in a consistent effect on reducing oxidative stress, and some beneficial
effects on BMI, blood cholesterol levels, and vascular function.
6. Raspberry
Black raspberry (Rubus occidentalis) is a flavonoid-rich member of the Rosaceae family common
in Japan, China, and South Korea, where it is traditionally used to treat prostate and urinary diseases.
It also contains significant amounts of tyrosol, resveratrol, tannins, and other phenolic acids [42].
In a 12-week, randomized, controlled intervention, a group of 77 Metabolic Syndrome patients
received 750 mg/day of black raspberry powder in the form of capsules or a fiber- and sugar-matched
control. Raspberry resulted in decreased total serum cholesterol and total/HDL-cholesterol ratio, with
no other changes in serum lipid profile. Inflammatory markers IL-6 and TNF-α significantly decreased,
and anti-inflammatory adiponectin significantly increased, while CRP, ICAM-1 and VCAM-1 were
unaffected. Brachial artery flow-mediated dilation significantly improved [42].
In a controlled, cross-over intervention on a group of 10 older overweight or obese men, the
short-term effect of relatively large amounts of lyophilized black raspberry powder (45 g/day for
four days) was evaluated in countering the post-prandial inflammatory effects of a high fat meal.
Serum IL-6 concentrations significantly decreased, but not TNF-α and CRP concentrations [41].
In conclusion, the impact of raspberry consumption on subjects with risk factor for Metabolic
Syndrome has been evaluated in only two interventions, documenting some positive effects on blood
cholesterol levels, inflammation and vascular function. Research is needed to investigate more fully
the potential of this berry.
7. Chokeberry
Chokeberry (Aronia melanocarpa) is a violet-black, strongly-flavored berry, common in areas of
North America and Eastern Europe. It is a rich source of polyphenols, particularly anthocyanins
present in form of cyanidin-glucosides, but also caffeic acid, quercetin, procyanidins, and other
flavonoids [46].
An 18-week intervention on a group of 58 overweight or obese men with mild
hypercholesterolemia who were given 150 mL/day of chokeberry juice for two, 6-week long periods
separated by a 6-week wash-out, resulted in decreased circulating levels of serum total and LDL
cholesterol and increased serum HDL2 cholesterol. Furthermore, serum triglycerides, glucose,
homocysteine, and fibrinogen levels also significantly decreased, as well as blood pressure, while
inflammatory markers hs-CRP protein and lipid peroxides were not affected [46].
Eight-week administration of 300 mg/day of chokeberry extract to a group of 52 middle-aged
individuals with Metabolic Syndrome, resulted in decreased levels of serum total and LDL cholesterol,
with no changes in total HDL cholesterol. Serum triglycerides were also significantly decreased, as well
as parameters of platelet aggregation and coagulation [45].
A 4-week intervention on 20 middle-aged, obese women with 100 mL/day of a glucomannan-
enriched chokeberry juice resulted in decreased BMI, waist circumference and systolic blood pressure.
However, no changes were observed in diastolic blood pressure, blood glucose levels, serum
triglycerides, total and LDL cholesterol, with increased levels of HDL cholesterol. Membrane
composition of erythrocytes was affected, with an increase in omega-3 polyunsaturated fatty acids and
a decrease in monounsaturated fatty acids [44].
Four week administration of 200 mL/day of chokeberry juice to a group of 23 hypertensive
subjects resulted in decreased systolic and diastolic blood pressure, but blood lipid profile, glucose
and C-reactive protein levels were unaffected [43].
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The effect of chokeberries on Metabolic Syndrome has been investigated in four intervention
studies, documenting some positive but not consistent effects on blood cholesterol and triglyceride
levels, blood pressure, and erythrocyte membrane fluidity. More research is needed to better investigate
the effects of this berry.
8. Strawberry
Besides being an important source of vitamin C, strawberries (Fragaria × ananassa) contain an
abundance of various phenolic compounds, including quercetin, ellagic acid, anthocyanins, catechins,
and kaempferol [54].
Following a controlled 7-week, randomized, cross-over intervention, 28 hyperlipidemic subjects
receiving a serving of strawberries (454 g/day) showed reduced LDL oxidative damage and a reduced
LDL-cholesterol molar ratio compared to control. No significant effect was observed for plasma levels
of conjugated dienes, lipid profile, C-reactive protein, blood pressure, and body weight [57].
An 8-week randomized, controlled trial on 27 subjects with Metabolic Syndrome receiving
two cups of a strawberry beverage (composed of 25 g of freeze-dried strawberry powder each)
daily for eight weeks, documented a reduction of total and LDL-cholesterol, small LDL particle size,
and VCAM-1. No significant effect was observed for glucose, triglycerides, HDL-cholesterol, blood
pressure, waist circumference, and ICAM-1 [55].
A 4-week intervention on 16 obese women with Metabolic Syndrome receiving two daily cups of
a strawberry drink (composed of 25 g of freeze-dried strawberry powder each), reported a significant
reduction in serum total and LDL-cholesterol levels, with no changes in HDL cholesterol, triglycerides,
blood glucose levels and blood pressure. Lipid peroxidation products malondialdehyde (MDA) and
4-hydroxynonenal (HNE) significantly decreased, but not plasma oxidized LDL, and inflammatory
markers hs-CRP and adiponectin [56].
A placebo-controlled, randomized, crossover 6-week intervention on 24 middle-aged, overweight
or obese hyperlipidemic subjects receiving a daily strawberry drink (composed of 10 g of freeze-dried
strawberry powder) did not find any differences in fasting triglycerides, cholesterol or plasma oxidized
LDL concentrations. However, when the postprandial response to a high-fat meal challenge was
evaluated at the end of the intervention, subjects who were on the strawberry group had significantly
lower triglycerides as well as total, LDL and HDL-cholesterol levels [54].
A placebo-controlled, randomized, 6-week intervention on 24 overweight subjects receiving the
same strawberry drink, found no changes in serum glucose, insulin, hs-CRP, IL-6, PAI-1, IL-1β, and
TNF-α concentrations. However, when a high carbohydrate and fat meal was given to the subjects at
the end of the intervention, serum PAI-1, IL-1β levels were significantly lower in the strawberry group,
but not serum glucose, insulin, hs-CRP, IL-6, and TNF-α levels [53].
When the post-prandial effect of a single-dose of the same strawberry drink was evaluated on a
group of 26 overweight individuals consuming a high-carbohydrate moderate-fat meal, without any
pre-intervention, serum hs-CRP, IL-6 and insulin levels were found to be significantly lower, but not
PAI-1, IL-1β, TNF-α, and blood glucose concentrations [52].
Following a controlled 7-week, randomized, cross-over intervention, 20 obese individuals
receiving two servings of strawberry powder (equivalent to 320 g/day of frozen strawberries) showed
a significant reduction in serum total and small HDL-cholesterol concentrations and in LDL particle
size. No changes in serum triglycerides and inflammatory markers and oxidative stress were observed,
but serum fibrinogen concentrations decreased [51].
When a group of 36 overweight subjects with type 2 diabetes received 50 g/day of freeze-dried
strawberry for six weeks in a placebo-controlled, randomized intervention, markers of total serum
antioxidant status significantly increased while serum malondialdehyde (MDA), glycated hemoglobin
HbA1c, and hs-CRP concentrations significantly decreased, and blood glucose levels remained
unaffected [50].
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In another controlled, randomized intervention, 36 overweight or obese subjects with type 2
diabetes received the same amount of freeze-dried strawberry for six weeks, resulting in a significantly
lower diastolic blood pressure, but with no changes in systolic blood pressure as well as serum
triglycerides and cholesterol levels [49].
In a 12-week, randomized, controlled intervention, 60 obese volunteers with risk factors for
cardiovascular disease were assigned to either a low-dose or high-dose strawberry treatment (25 or
50 g freeze-dried strawberry powder in water, respectively), or a calorie- and fiber-matched control.
At the end of the intervention, malondialdehyde (MDA) and 4-hydroxynonenal (HNE) significantly
decreased with both doses, but a significant reduction in serum total and LDL-cholesterol, and derived
small LDL particles, was only observed in the high-dose group. Serum glucose, glycated hemoglobin
HbA1c, insulin, HDL, VLDL-cholesterol, HOMA-IR score, triglycerides, VCAM-1, ICAM-1, and
hs-CRP did not change significantly [48].
When a single serving of freeze-dried strawberry powder at different doses (0, 10, 20 or 40 g)
was given to a group of 21 abdominally obese subjects with insulin resistance, a significant reduction
in post-prandial plasma insulin concentrations, insulin:glucose ratio, and rate of glucose and insulin
increase was only observed after consumption of the highest dose. Interestingly, a significant reduction
in plasma oxidized LDLs was observed after the 20 g dose, but not after the 40 g dose. Plasma glucose,
triglycerides and IL-6 levels did not change at any dose [47].
Thus, ten studies focused on the role of strawberries on Metabolic Syndrome and its risk factors.
Overall, strawberry consumption led to some improvements in oxidative stress, inflammatory status,
blood lipid profile, and blood pressure, although these effects were not consistent.
9. Whortleberry
Caucasian whortleberry, or qaraqat (Vaccinium arctostaphylos), is a wild berry, common in Western
Asia with high anthocyanin content [58]. In a 4-week, placebo-controlled, randomized intervention
on 50 hyperlipidemic subjects, two daily capsules of whortleberry extract containing 45 mg of
anthocyanins each, resulted in lower serum concentrations of total and LDL cholesterol, triglycerides,
and MDA, without changes in HDL-cholesterol and inflammatory marker hs-CRP [47]. Due to the
paucity of data regarding this berry, more research is needed to investigate its effects.
10. Berry Mix
Considering the positive results obtained from single-berry studies, some research groups tested
the effect of a mix of berries in randomized interventions.
In a 12-week, placebo-controlled study on 133 older, borderline or hypertensive subjects,
consumption of 500 mL/day of a juice made from red grapes, cherries, chokeberries, and bilberries
resulted in significantly lower systolic blood pressure after six, but not after 12 week consumption ,
and no effect on diastolic pressure. When only the hypertensive sub-group was considered, the blood
pressure lowering effect was more pronounced [59].
In a 12 week intervention on 20 overweight or obese subjects with Metabolic Syndrome risk
factors, daily combined consumption of 100 g strawberry purée, 100 g of frozen raspberries, and 100 g
of frozen cloudberries, resulted in lower serum leptin levels but did not affect blood pressure, serum
lipid profile, resistin, and markers of oxidative stress [60].
In a 20 week intervention on 61 overweight or obese women with Metabolic Syndrome, a daily
mix of 163 g of lingonberry, sea buckthorn berry, bilberry, and black currant resulted in higher
anti-inflammatory adiponectin plasma concentrations, but did not affect blood pressure, blood lipid or
glucose levels, markers of oxidative stress, and other markers of inflammation [61].
More studies investigating the effects of a mix of multiple berries would be useful, since berries
are often commercialized in mixes, both as fresh products but above all in juices, smoothies, purees,
and other products.
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11. Remarks and Conclusions
In the US, more than one in every five adults meets the diagnostic criteria for Metabolic
Syndrome [64]. In turn, this condition dramatically increases the risk of developing type II diabetes
and suffering acute cardiovascular events, such as heart attacks or strokes [1]. Thus, finding economic
and effective ways to prevent and reverse Metabolic Syndrome is of key importance for public health.
Several lines of evidence suggest that diet, together with regular physical activity and avoidance
of smoking, is one of the most manageable ways of preventing the development of Metabolic Syndrome
in the human population, and at the same time it is also a tool to mitigate the symptoms and decrease
the risk of complications in patients who already suffer from this condition.
Furthermore, diet has the potential to greatly reduce the need for pharmacological treatment,
which is inevitably associated with harmful side effects and constitutes a considerable financial burden.
Being a multifactorial condition, the pharmacological approach to Metabolic Syndrome requires the use
of multiple medications, to control a wide array of metabolic abnormalities ranging from dyslipidemia
to hypertension, and from hypercholesterolemia to impaired blood glucose control. Thus, the risk of
side effects is multiplied by the need of administering multiple medications, and the opportunity to
be able to prevent or even control some of the same metabolic dysfunctions with lifestyle—including
diet—becomes especially advantageous.
Mounting evidence suggests that consumption of dietary achievable amounts of berries, whose
distinctive nutritional characteristic is the abundance of phenolic compounds, has the potential to
affect several metabolic abnormalities related to Metabolic Syndrome.
When results of the dietary interventions reviewed in this article are considered together, it appears
that the stronger and most recurrent effects of berry consumption lie in their anti-inflammatory
and anti-oxidant effects. They also have a tendency to improve lipid profile, lowering total and
LDL-cholesterol as well as triglycerides, but this outcome is not observed consistently. It is reasonable
to speculate that inter-individual variability as well as interactions with the rest of the diet, are strong
enough to mask the effects of berry consumption on lipid profile, and this seems to be confirmed
by the observation that effects on blood lipids tend to reach statistical significance in subjects with
particularly abnormal baseline values.
Several studies also report positive effects in attenuating blood pressure, especially systolic
blood pressure in hypertensive subjects, and some studies document positive effects on markers of
endothelial function.
As far as the effects on glucose and insulin metabolism are concerned, results are mixed and tend
to be absent, in a few studies even negative. It is possible that in subjects whose glucose and insulin
metabolism is already severely impaired, the benefits of phenolic compounds are outweighed by the
sugar content of berries, especially when given in form of juices and not with meals.
Another recurring observation in studies testing multiple doses is that there exists a dose-response
effect, and some positive outcomes are only observed at higher levels of consumption or with
longer interventions.
Considering the overall positive effects of berry consumption that have been reported in several
dietary interventions on multiple metabolic abnormalities related to Metabolic Syndrome, it appears
that regular berry consumption is a promising strategy to prevent Metabolic Syndrome and its
complications, certainly not by itself as a single-bullet solution, but as part of a varied, balanced, and
healthy dietary approach promoting health and preventing disease.
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